Action sites and clinical application of HIF-1α inhibitors
R Xu, F Wang, H Yang, Z Wang - Molecules, 2022 - mdpi.com
Hypoxia-inducible factor-1α (HIF-1α) is widely distributed in human cells, and it can form
different signaling pathways with various upstream and downstream proteins, mediate …
different signaling pathways with various upstream and downstream proteins, mediate …
HIF-1: structure, biology and natural modulators
Y Chao, ZF Zhong, W Sheng-Peng, V Chi-Teng… - Chinese Journal of …, 2021 - Elsevier
Abstract Hypoxia-inducible factor 1 (HIF-1), as a main transcriptional regulator of metabolic
adaptation to changes in the oxygen environment, participates in many physiological and …
adaptation to changes in the oxygen environment, participates in many physiological and …
Hypoxia-inducible factor 1-related diseases and prospective therapeutic tools
JW Park, YS Chun, MS Kim - Journal of pharmacological sciences, 2004 - Elsevier
Abstract Hypoxia-inducible factor 1 (HIF-1) is a transcription factor that functions as a master
regulator of oxygen homeostasis. HIF-1 regulates the expressions of the proteins that …
regulator of oxygen homeostasis. HIF-1 regulates the expressions of the proteins that …
Recent advances in hypoxia-inducible factor (HIF)-1 inhibitors
Y Xia, HK Choi, K Lee - European journal of medicinal chemistry, 2012 - Elsevier
Tumor hypoxia has been recognized as a common feature of solid tumors and a negative
prognostic factor for response to treatment and survival of cancer patients. The discovery of …
prognostic factor for response to treatment and survival of cancer patients. The discovery of …
Recent agents targeting HIF‐1α for cancer therapy
Y Hu, J Liu, H Huang - Journal of cellular biochemistry, 2013 - Wiley Online Library
The discovery of hypoxia‐inducible factor‐1 (HIF‐1) has led to an increasing understanding
of the mechanism of tumor hypoxia in the past two decades. As a key transcriptional …
of the mechanism of tumor hypoxia in the past two decades. As a key transcriptional …
Hypoxia‐inducible factor‐1 (HIF‐1) inhibitors from the last decade (2007 to 2016): A “structure–activity relationship” perspective
D Bhattarai, X Xu, K Lee - Medicinal research reviews, 2018 - Wiley Online Library
Tumor hypoxia is a common feature in most solid tumors and is associated with
overexpression of the hypoxia response pathway. Overexpression of the hypoxia‐inducible …
overexpression of the hypoxia response pathway. Overexpression of the hypoxia‐inducible …
Cancer therapeutic agents targeting hypoxia-inducible factor-1
R Wang, S Zhou, S Li - Current medicinal chemistry, 2011 - ingentaconnect.com
The discovery of hypoxia-inducible factor-1 has led to a rapidly increasing understanding of
the molecular mechanism of tumor hypoxia in the past two decades. Today it is generally …
the molecular mechanism of tumor hypoxia in the past two decades. Today it is generally …
Hypoxia-inducible factor (HIF-1) α: its protein stability and biological functions
JW Lee, SH Bae, JW Jeong, SH Kim… - Experimental & molecular …, 2004 - nature.com
Abstract Hypoxia-inducible factor (HIF-1) is an oxygen-dependent transcriptional activator,
which plays crucial roles in the angiogenesis of tumors and mammalian development. HIF-1 …
which plays crucial roles in the angiogenesis of tumors and mammalian development. HIF-1 …
[HTML][HTML] HIF-1α pathway: role, regulation and intervention for cancer therapy
GN Masoud, W Li - Acta Pharmaceutica Sinica B, 2015 - Elsevier
Abstract Hypoxia-inducible factor-1 (HIF-1) has been recognized as an important cancer
drug target. Many recent studies have provided convincing evidences of strong correlation …
drug target. Many recent studies have provided convincing evidences of strong correlation …
Kinases as upstream regulators of the HIF system: their emerging potential as anti-cancer drug targets
EY Dimova, C Michiels… - Current pharmaceutical …, 2009 - ingentaconnect.com
The hypoxia-inducible factor-1 (HIF-1) is a key regulator in the mammalian response to
oxygen deficiency under both physiological and pathological conditions such as cancer. A …
oxygen deficiency under both physiological and pathological conditions such as cancer. A …